Really no need to apologize smit, you write as you feel, just like most every other poster here, including myself. GNTA, like any other stock, is a tough one to follow and no-one really knows what the future brings for it. As far as those thinking it is a shoe in for FDA approval, yes, the article recently posted does have a promising aspect as to its benefits, yet that is only one part of FDA study. Drugs are also tested/weighed in many areas to see if the benefits outweigh the risks of possible damage to the body in other ways. Remember, the pharma producing a drug is a bit more biased toward how their drugs may benefit, their studies may be somewhat less focused on other areas of the body which may not. The FDA must look at the picture as a whole and study accordingly. The good thing is that maybe upon previous denial, an FDA report may have provided pertinent information in areas which they were concerned and the pharma improved upon those areas. Who knows though until a few weeks or so from now?!
News 
Market Data 
Discover 
